With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Operate with a strong cross‑functional and execution‑driven mindset, working closely with Supply Chain, Legal, Finance, Portfolio Management, Procurement, Regulatory, IP, and Commercial teams, while ensuring strict adherence to timelines, milestones, and governance standards
mehr